Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update May 11, 2009 Tekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update 12.9 KB ... Read more Summary ToggleRoche Partners with Tekmira Pharmaceuticals to Advance RNAi Product Candidates May 11, 2009 Roche Partners with Tekmira Pharmaceuticals to Advance RNAi Product Candidates 12.9 KB ... Read more Summary ToggleTekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial May 07, 2009 Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial 18 KB ... Read more Summary ToggleTekmira Pharmaceuticals Files IND for ApoB SNALP Apr 14, 2009 Tekmira Pharmaceuticals Files IND for ApoB SNALP 17.2 KB ... Read more Summary ToggleTekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment Apr 03, 2009 Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment 18.5 KB ... Read more Summary ToggleTekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 Mar 25, 2009 Tekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 17.2 KB ... Read more Summary ToggleTekmira Pharmaceuticals Reports 2008 Audited Results and Provides Corporate Update Mar 24, 2009 Tekmira Pharmaceuticals Reports 2008 Audited Results and Provides Corporate Update 32.6 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Mar 18, 2009 Tekmira Pharmaceuticals Conference Call Advisory 12.7 KB 2008 Audited Results and Corporate Update ... Read more Summary ToggleTekmira Presents Data Demonstrating Further Increases in SNALP Potency Feb 24, 2009 Tekmira Presents Data Demonstrating Further Increases in SNALP Potency 17.8 KB ... Read more Summary ToggleTekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data Feb 23, 2009 Tekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data 17.8 KB ... Read more Pagination First page First Previous page Previous … Page 48 Current page 49 Page 50 Page 51 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update May 11, 2009 Tekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update 12.9 KB ... Read more Summary ToggleRoche Partners with Tekmira Pharmaceuticals to Advance RNAi Product Candidates May 11, 2009 Roche Partners with Tekmira Pharmaceuticals to Advance RNAi Product Candidates 12.9 KB ... Read more Summary ToggleTekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial May 07, 2009 Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial 18 KB ... Read more Summary ToggleTekmira Pharmaceuticals Files IND for ApoB SNALP Apr 14, 2009 Tekmira Pharmaceuticals Files IND for ApoB SNALP 17.2 KB ... Read more Summary ToggleTekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment Apr 03, 2009 Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment 18.5 KB ... Read more Summary ToggleTekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 Mar 25, 2009 Tekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 17.2 KB ... Read more Summary ToggleTekmira Pharmaceuticals Reports 2008 Audited Results and Provides Corporate Update Mar 24, 2009 Tekmira Pharmaceuticals Reports 2008 Audited Results and Provides Corporate Update 32.6 KB ... Read more Summary ToggleTekmira Pharmaceuticals Conference Call Advisory Mar 18, 2009 Tekmira Pharmaceuticals Conference Call Advisory 12.7 KB 2008 Audited Results and Corporate Update ... Read more Summary ToggleTekmira Presents Data Demonstrating Further Increases in SNALP Potency Feb 24, 2009 Tekmira Presents Data Demonstrating Further Increases in SNALP Potency 17.8 KB ... Read more Summary ToggleTekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data Feb 23, 2009 Tekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data 17.8 KB ... Read more Pagination First page First Previous page Previous … Page 48 Current page 49 Page 50 Page 51 … Next page Next Last page Last
Tekmira Pharmaceuticals Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update 12.9 KB
Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial 18 KB
Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial in Patients with Liver Cancer. First Clinical Trial Utilizing SNALP Triggers Milestone Payment 18.5 KB
Tekmira Pharmaceuticals Extends Research Collaboration with Bristol-Myers Squibb through 2009 17.2 KB
